Kwang A Kim

US Patent:

8114892, Feb 14, 2012

Filed:

Feb 15, 2007

Appl. No.:

12/279473

Inventors:

Deog Joong Kim - Rockville MD, US
Chun Hyung Kim - Lexington MA, US
Kwang Soo Kim - Lexington MA, US

Assignee:

The McLean Hospital Corporation - Belmont MA

International Classification:

A61K 31/4706
A61P 25/16
A61P 33/06

US Classification:

514311, 514 46, 514 177, 514 182

Abstract:

The invention features methods and kits for treating or inhibiting the development of Parkinson's Disease by administering 7-chloro-4-aminoquinoline compounds, e. g. , amodiaquine or glafenine. Stem cells are also useful in the methods of the invention and may be administered separately from or together with 7-chloro-4-aminoquinoline compounds. The invention further features methods of identifying additional chemical compounds that are useful in the treatment or inhibition of the development of Parkinson's Disease.

US Patent:

8298522, Oct 30, 2012

Filed:

May 15, 2006

Appl. No.:

11/435109

Inventors:

Kwang Chul Kim - Ellicott City MD, US

International Classification:

A61K 45/00
A61K 39/00

US Classification:

424 851, 4241841

Abstract:

The present invention relates generally to the field of inflammation. More particularly, the present invention relates to reducing release of pro-inflammatory cytokines induced to MUC1 activity. In one aspect, the present invention provides a method of modulating (inhibiting or promoting) an inflammatory response wherein modulation of the inflammatory response is desired, comprising administering an effective amount of an agent which inhibits or promotes MUC-1 function to an individual.

US Patent:

20010033827, Oct 25, 2001

Filed:

May 17, 2001

Appl. No.:

09/858542

Inventors:

Kwang Kim - Ellicott City MD, US

International Classification:

A61K038/16
A61K009/00

US Classification:

424/043000, 514/002000

Abstract:

Polycationic peptides have been shown to be effective inhibitors of mucin secretion. Inhibition of mucin secretion using these polycationic peptides may be an important tool in the treatment of diseases associated with mucin hypersecretion, including asthma, chronic bronchitis, cystic fibrosis, and bronchiectasis.

US Patent:

20050259668, Nov 24, 2005

Filed:

May 24, 2004

Appl. No.:

10/851892

Inventors:

Kwang Kim - Vienna VA, US

International Classification:

H04L012/66

US Classification:

370401000

Abstract:

A method and apparatus for implementing wireless internet connections for a plurality of portable computing devices located within a given area or hotspot. The invention employs a combination of wired and wireless links to manage propagation effects of the transmitted signal and to reduce interference with signals transmitted in adjacent spaces. In accordance with one aspect of the invention, the existing wiring infrastructure at the hotspot, which may be coaxial cable for CATV, is used as the wired segment. A broadband signal, containing internet data obtained from a central computer, is transmitted from a plurality of access points. The signals transmitted from the access points are injected onto the existing wiring, with the broadband signal isolated from the data or power signals carried by the wiring infrastructure. At the outlet ends of the coaxial cable, the broadband signals are separated from the existing data or power signals and coupled to high efficiency antennas which radiate a signal throughout the corresponding living or activity space. In the case of a hotel room, for example, the signal is broadcast for reception anywhere within the hotel room. In accordance with one aspect of the method of the invention, the broadband signals are broadcast from the various access points using several carrier frequencies or channels, and distribution of the channels is arranged to avoid adjacent room same channel interference.

US Patent:

20100136027, Jun 3, 2010

Filed:

Apr 6, 2007

Appl. No.:

12/226088

Inventors:

Kwang S. Kim - Reisterstown MD, US

Assignee:

The Johns Hopkins University - Baltimore MD

International Classification:

A61K 39/40
A61K 39/108
C12Q 1/68
C12N 15/63
C12N 1/21
C07K 16/00
A61P 31/04

US Classification:

4241641, 4242571, 435 6, 4353201, 43525233, 5303895

Abstract:

The present invention relates to methods and compositions for the treatment of bacterial infection, for example extraintestinal infection such as bacteremia, meningitis and sepsis. The invention relates also to methods of diagnosis and prevention.

US Patent:

62453203, Jun 12, 2001

Filed:

Sep 1, 1999

Appl. No.:

9/387501

Inventors:

Kwang Chul Kim - Ellicott City MD

Assignee:

University of Maryland - Baltimore MD

International Classification:

A61K 972
A61K 3803
A61K 3808
A61K 3810
A61K 3816

US Classification:

424 43

Abstract:

Polycationic peptides have been shown to be effective inhibitors of mucin secretion. Inhibition of mucin secretion using these polycationic peptides may be an important tool in the treatment of diseases associated with mucin hypersecretion, including asthma, chronic bronchitis, cystic fibrosis, and bronchiectasis.

Address:

2 Whisperwood Ct, Rockville, MD 20852

VIN:

5NPEU46FX8H318722

Make:

HYUNDAI

Model:

SONATA

Year:

2008

Address:

14101 Stanwood Ter APT 304, Rockville, MD 20850

VIN:

2HGFG12697H558708

Make:

HONDA

Model:

CIVIC

Year:

2007